2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
100
-0.0%
136.05
USD 13,605
|
100
-0.0%
|
136.05
|
USD 13,605
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
300
-0.1%
135.24
USD 40,573
|
300
-0.1%
|
135.24
|
USD 40,573
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
400
-0.2%
133.86
USD 53,544
|
400
-0.2%
|
133.86
|
USD 53,544
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,050
-0.4%
133.28
USD 139,939
|
1,050
-0.4%
|
133.28
|
USD 139,939
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,220
-0.5%
132.04
USD 161,091
|
1,220
-0.5%
|
132.04
|
USD 161,091
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
355
-0.9%
140.94
USD 50,034
|
355
-0.9%
|
140.94
|
USD 50,034
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
395
-1.0%
140.00
USD 55,301
|
395
-1.0%
|
140.00
|
USD 55,301
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
490
-1.2%
138.55
USD 67,889
|
490
-1.2%
|
138.55
|
USD 67,889
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
260
-0.6%
137.08
USD 35,641
|
260
-0.6%
|
137.08
|
USD 35,641
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
100
-0.2%
141.28
USD 14,128
|
100
-0.2%
|
141.28
|
USD 14,128
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
287
-0.7%
140.57
USD 40,343
|
287
-0.7%
|
140.57
|
USD 40,343
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
396
-1.0%
139.56
USD 55,265
|
396
-1.0%
|
139.56
|
USD 55,265
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
477
-1.1%
138.57
USD 66,097
|
477
-1.1%
|
138.57
|
USD 66,097
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
240
-0.6%
136.99
USD 32,876
|
240
-0.6%
|
136.99
|
USD 32,876
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
197
-2.0%
142.82
USD 28,136
|
197
-2.0%
|
142.82
|
USD 28,136
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
365
-3.6%
142.25
USD 51,923
|
365
-3.6%
|
142.25
|
USD 51,923
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,528
-13.0%
141.13
USD 215,644
|
1,528
-13.0%
|
141.13
|
USD 215,644
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,512
-11.4%
140.17
USD 211,944
|
1,512
-11.4%
|
140.17
|
USD 211,944
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
398
-2.9%
139.33
USD 55,455
|
398
-2.9%
|
139.33
|
USD 55,455
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
439
-0.3%
141.90
USD 62,294
|
439
-0.3%
|
141.90
|
USD 62,294
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,270
-0.9%
140.70
USD 178,684
|
1,270
-0.9%
|
140.70
|
USD 178,684
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,291
-0.9%
139.78
USD 180,450
|
1,291
-0.9%
|
139.78
|
USD 180,450
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,334
-0.7%
142.28
USD 189,801
|
1,334
-0.7%
|
142.28
|
USD 189,801
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
4,022
-2.0%
141.11
USD 567,557
|
4,022
-2.0%
|
141.11
|
USD 567,557
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
8,027
-3.8%
140.20
USD 1,125,400
|
8,027
-3.8%
|
140.20
|
USD 1,125,400
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
2,515
-1.2%
139.39
USD 350,572
|
2,515
-1.2%
|
139.39
|
USD 350,572
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
68
-0.1%
138.36
USD 9,408
|
68
-0.1%
|
138.36
|
USD 9,408
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
2,494
-3.2%
138.41
USD 345,195
|
2,494
-3.2%
|
138.41
|
USD 345,195
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
252
-0.1%
138.42
USD 34,881
|
252
-0.1%
|
138.42
|
USD 34,881
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
9,311
-4.2%
138.41
USD 1,288,736
|
9,311
-4.2%
|
138.41
|
USD 1,288,736
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
37
-0.0%
138.39
USD 5,120
|
37
-0.0%
|
138.39
|
USD 5,120
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
1,367
-0.6%
138.41
USD 189,207
|
1,367
-0.6%
|
138.41
|
USD 189,207
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
490
-1.2%
146.78
USD 71,921
|
490
-1.2%
|
146.78
|
USD 71,921
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,010
-2.3%
145.21
USD 146,664
|
1,010
-2.3%
|
145.21
|
USD 146,664
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
430
-1.0%
146.78
USD 63,117
|
430
-1.0%
|
146.78
|
USD 63,117
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,070
-2.5%
145.09
USD 155,251
|
1,070
-2.5%
|
145.09
|
USD 155,251
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
630
-0.2%
146.81
USD 92,493
|
630
-0.2%
|
146.81
|
USD 92,493
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
53
-0.0%
145.60
USD 7,717
|
53
-0.0%
|
145.60
|
USD 7,717
|
|
2025-03-19 |
2025-03-18 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
2,017
-0.8%
145.17
USD 292,817
|
2,017
-0.8%
|
145.17
|
USD 292,817
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
2
-0.0%
149.58
USD 299
|
2
-0.0%
|
149.58
|
USD 299
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
790
-1.1%
146.03
USD 115,362
|
790
-1.1%
|
146.03
|
USD 115,362
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
6,702
-3.2%
146.03
USD 978,678
|
6,702
-3.2%
|
146.03
|
USD 978,678
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
181
-0.1%
146.03
USD 26,431
|
181
-0.1%
|
146.03
|
USD 26,431
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
Officer
|
2
-0.0%
149.58
USD 299
|
2
-0.0%
|
149.58
|
USD 299
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
Officer
|
793
-0.5%
146.03
USD 115,800
|
793
-0.5%
|
146.03
|
USD 115,800
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
2
-0.0%
149.74
USD 299
|
2
-0.0%
|
149.74
|
USD 299
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
926
-0.4%
146.03
USD 135,222
|
926
-0.4%
|
146.03
|
USD 135,222
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
3
-0.0%
149.74
USD 449
|
3
-0.0%
|
149.74
|
USD 449
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,023
-0.7%
146.03
USD 149,386
|
1,023
-0.7%
|
146.03
|
USD 149,386
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
3
-0.0%
149.58
USD 449
|
3
-0.0%
|
149.58
|
USD 449
|
|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
1,124
-0.0%
146.03
USD 164,135
|
1,124
-0.0%
|
146.03
|
USD 164,135
|
|
2025-03-14 |
2025-03-14 |
S
Sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
300
-0.0%
149.00
USD 44,700
|
300
-0.0%
|
149.00
|
USD 44,700
|
|
2025-03-14 |
2025-03-14 |
S
Sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
13,935
-0.6%
148.38
USD 2,067,696
|
13,935
-0.6%
|
148.38
|
USD 2,067,696
|
|
2025-03-14 |
2025-03-14 |
S
Sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
29,967
-1.2%
147.64
USD 4,424,187
|
29,967
-1.2%
|
147.64
|
USD 4,424,187
|
|
2025-03-14 |
2025-03-14 |
S
Sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
4,798
-0.2%
146.58
USD 703,296
|
4,798
-0.2%
|
146.58
|
USD 703,296
|
|
2025-03-14 |
2025-03-14 |
S
Sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
1,000
-0.0%
145.37
USD 145,369
|
1,000
-0.0%
|
145.37
|
USD 145,369
|
|
2025-03-14 |
2025-03-12 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
381
-3.8%
149.27
USD 56,873
|
381
-3.8%
|
149.27
|
USD 56,873
|
|
2025-03-14 |
2025-03-12 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,682
-14.3%
148.71
USD 250,127
|
1,682
-14.3%
|
148.71
|
USD 250,127
|
|
2025-03-14 |
2025-03-12 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
923
-7.3%
147.20
USD 135,867
|
923
-7.3%
|
147.20
|
USD 135,867
|
|
2025-03-14 |
2025-03-12 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,014
-7.4%
145.86
USD 147,907
|
1,014
-7.4%
|
145.86
|
USD 147,907
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
400
-0.3%
144.97
USD 57,988
|
400
-0.3%
|
144.97
|
USD 57,988
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,700
-1.2%
144.12
USD 245,009
|
1,700
-1.2%
|
144.12
|
USD 245,009
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
2,700
-1.8%
143.05
USD 386,239
|
2,700
-1.8%
|
143.05
|
USD 386,239
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,200
-0.8%
142.08
USD 170,499
|
1,200
-0.8%
|
142.08
|
USD 170,499
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
900
-0.4%
145.42
USD 130,878
|
900
-0.4%
|
145.42
|
USD 130,878
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
10,320
-4.8%
144.75
USD 1,493,794
|
10,320
-4.8%
|
144.75
|
USD 1,493,794
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
33,776
-13.6%
144.02
USD 4,864,284
|
33,776
-13.6%
|
144.02
|
USD 4,864,284
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
30,298
-10.9%
142.79
USD 4,326,194
|
30,298
-10.9%
|
142.79
|
USD 4,326,194
|
|
2025-03-07 |
2025-03-05 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
11,978
-4.1%
141.91
USD 1,699,855
|
11,978
-4.1%
|
141.91
|
USD 1,699,855
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
96
-0.2%
162.64
USD 15,613
|
96
-0.2%
|
162.64
|
USD 15,613
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
296
-0.7%
161.64
USD 47,846
|
296
-0.7%
|
161.64
|
USD 47,846
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
744
-1.7%
160.85
USD 119,674
|
744
-1.7%
|
160.85
|
USD 119,674
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
292
-0.7%
158.88
USD 46,394
|
292
-0.7%
|
158.88
|
USD 46,394
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
72
-0.2%
155.66
USD 11,208
|
72
-0.2%
|
155.66
|
USD 11,208
|
|
2025-02-28 |
2025-02-26 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
100
-0.2%
162.64
USD 16,264
|
100
-0.2%
|
162.64
|
USD 16,264
|
|